Business Context and Reporting Period
This Form 8-K was filed by Bausch Health Companies Inc. on May 20, 2025. The report details the entry into material definitive agreements regarding corporate governance and board composition.
Financial Metrics
This filing does not contain financial performance data. There are no reported figures for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The primary material change is the execution of Letter Agreements on May 20, 2025, between the Company and three major shareholder groups: the Icahn Group, the Paulson Group, and the Kavanagh Group. These agreements govern the conduct of overlapping directors on the Bausch Health (BHC) and Bausch + Lomb (B+L) boards.
Guidance, Outlook, and Management Commentary
The filing outlines specific conditions under which the shareholder groups must tender their resignations from the BHC and B+L boards. These conditions, termed "Specified Actions," include:
- Instigating or supporting a proxy contest against the Company.
- Presenting shareholder proposals or soliciting proxies/consents.
- Granting proxies or depositing voting securities in a voting trust (with exceptions).
- Seeking nominations for a contested director election.
- Acquiring voting securities that would result in the Icahn Group beneficially owning more than 19.99% of outstanding common shares.
Conversely, if no Specified Action occurs, the Company agrees to vote its B+L securities for Group Designees named as management nominees and to appoint them to new BHC board committees absent conflicts of interest. The Icahn Group also waived specific rights under a 2022 Director Appointment and Nomination Agreement.
Key Facts for Investor Verification
- Verify the full text of the attached Letter Agreements (Exhibits 10.2, 10.3, and 10.4) to understand specific exceptions to the "Specified Actions."
- Confirm the current beneficial ownership percentages of the Icahn, Paulson, and Kavanagh Groups to assess proximity to the 19.99% threshold.
- Review the composition of the BHC and B+L boards to identify which directors are subject to these resignation triggers.
- Monitor for any upcoming shareholder meetings where proxy contests or proposals might be initiated by these groups.